{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:45:59Z","timestamp":1781628359629,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21be0404008"],"award-info":[{"award-number":["JP21be0404008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21be0404008"],"award-info":[{"award-number":["JP21be0404008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21be0404008"],"award-info":[{"award-number":["JP21be0404008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"iPS Cell Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pluripotent stem-cell derived cells can be used for type I diabetes treatment, but we require at least 10<jats:sup>5<\/jats:sup>\u201310<jats:sup>6<\/jats:sup> islet-like clusters per patient. Although thousands of uniform cell clusters can be produced using a conventional microwell plate, numerous obstacles need to be overcome for its clinical use. In this study, we aimed to develop a novel bag culture method for the production of uniform cell clusters on a large scale (10<jats:sup>5<\/jats:sup>\u201310<jats:sup>6<\/jats:sup> clusters). We prepared small-scale culture bags (&lt;\u200910<jats:sup>5<\/jats:sup> clusters) with microwells at the bottom and optimized the conditions for producing uniform-sized clusters in the bag using undifferentiated induced pluripotent stem cells (iPSCs). Subsequently, we verified the suitability of the bag culture method using iPSC-derived pancreatic islet cells (iPICs) and successfully demonstrate the production of 6.5\u2009\u00d7\u200910<jats:sup>5<\/jats:sup> uniform iPIC clusters using a large-scale bag. In addition, we simplified the pre- and post-process of the culture\u2014a degassing process before cell seeding and a cluster harvesting process. In conclusion, compared with conventional methods, the cluster production method using bags exhibits improved scalability, sterility, and operability for both clinical and research use.<\/jats:p>","DOI":"10.1038\/s41598-022-09124-w","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T19:02:57Z","timestamp":1648234977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Microwell bag culture for large-scale production of homogeneous islet-like clusters"],"prefix":"10.1038","volume":"12","author":[{"given":"Ryo","family":"Suenaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Konagaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Yamaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"9124_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka, S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell 27, 523\u2013531. https:\/\/doi.org\/10.1016\/j.stem.2020.09.014 (2020).","journal-title":"Cell Stem Cell"},{"key":"9124_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0140-6736(17)31366-1","volume":"391","author":"G Cossu","year":"2018","unstructured":"Cossu, G. et al. Lancet commission: Stem cells and regenerative medicine. Lancet 391, 883\u2013910. https:\/\/doi.org\/10.1016\/S0140-6736(17)31366-1 (2018).","journal-title":"Lancet"},{"key":"9124_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","volume":"159","author":"FW Pagliuca","year":"2014","unstructured":"Pagliuca, F. W. et al. Generation of functional human pancreatic \u03b2 cells in vitro. Cell 159, 428\u2013439. https:\/\/doi.org\/10.1016\/j.cell.2014.09.040 (2014).","journal-title":"Cell"},{"key":"9124_CR4","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2337\/dc15-1988","volume":"39","author":"BJ Hering","year":"2016","unstructured":"Hering, B. J. et al. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care 39, 1230\u20131240. https:\/\/doi.org\/10.2337\/dc15-1988 (2016).","journal-title":"Diabetes Care"},{"key":"9124_CR5","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/ajt.16174","volume":"21","author":"JF Markmann","year":"2021","unstructured":"Markmann, J. F. et al. Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes. Am. J. Transplant. 21, 1477\u20131492. https:\/\/doi.org\/10.1111\/ajt.16174 (2021).","journal-title":"Am. J. Transplant."},{"key":"9124_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.2337\/db06-0779","volume":"56","author":"R Lehmann","year":"2007","unstructured":"Lehmann, R. et al. Superiority of small islets in human islet transplantation. Diabetes 56, 594\u2013603. https:\/\/doi.org\/10.2337\/db06-0779 (2007).","journal-title":"Diabetes"},{"key":"9124_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/isl.3.1.14131","volume":"3","author":"Y Fujita","year":"2011","unstructured":"Fujita, Y. et al. Large human islets secrete less insulin per islet equivalent than smaller islets in vitro. Islets 3, 1\u20135. https:\/\/doi.org\/10.4161\/isl.3.1.14131 (2011).","journal-title":"Islets"},{"key":"9124_CR8","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1007\/s00125-018-4672-5","volume":"61","author":"Y Yu","year":"2018","unstructured":"Yu, Y. et al. Bioengineered human pseudoislets form efficiently from donated tissue, compare favourably with native islets in vitro and restore normoglycaemia in mice. Diabetologia 61, 2016\u20132029. https:\/\/doi.org\/10.1007\/s00125-018-4672-5 (2018).","journal-title":"Diabetologia"},{"key":"9124_CR9","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/jcmm.12555","volume":"19","author":"J Hilderink","year":"2015","unstructured":"Hilderink, J. et al. Controlled aggregation of primary human pancreatic islet cells leads to glucose-responsive pseudoislets comparable to native islets. J. Cell. Mol. Med. 19, 1836\u20131846. https:\/\/doi.org\/10.1111\/jcmm.12555 (2015).","journal-title":"J. Cell. Mol. Med."},{"key":"9124_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/978-1-62703-128-8_32","volume":"946","author":"J Antonchuk","year":"2013","unstructured":"Antonchuk, J. Formation of embryoid bodies from human pluripotent stem cells using AggreWell\u2122 plates. Methods Mol. Biol. 946, 523\u2013533. https:\/\/doi.org\/10.1007\/978-1-62703-128-8_32 (2013).","journal-title":"Methods Mol. Biol."},{"key":"9124_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41586-019-1168-5","volume":"569","author":"A Veres","year":"2019","unstructured":"Veres, A. et al. Charting cellular identity during human in vitro \u03b2-cell differentiation. Nature 569, 368\u2013373. https:\/\/doi.org\/10.1038\/s41586-019-1168-5 (2019).","journal-title":"Nature"},{"key":"9124_CR12","doi-asserted-by":"publisher","first-page":"31063","DOI":"10.1038\/srep31063","volume":"6","author":"H Sato","year":"2016","unstructured":"Sato, H., Idiris, A., Miwa, T. & Kumagai, H. Microfabric vessels for embryoid body formation and rapid differentiation of pluripotent stem cells. Sci. Rep. 6, 31063. https:\/\/doi.org\/10.1038\/srep31063 (2016).","journal-title":"Sci. Rep."},{"key":"9124_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41587-020-0430-6","volume":"38","author":"NJ Hogrebe","year":"2020","unstructured":"Hogrebe, N. J., Augsornworawat, P., Maxwell, K. G., Velazco-Cruz, L. & Millman, J. R. Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells. Nat. Biotechnol. 38, 460\u2013470. https:\/\/doi.org\/10.1038\/s41587-020-0430-6 (2020).","journal-title":"Nat. Biotechnol."},{"key":"9124_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41556-018-0271-4","volume":"21","author":"GG Nair","year":"2019","unstructured":"Nair, G. G. et al. Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived \u03b2 cells. Nat. Cell Biol. 21, 263\u2013274. https:\/\/doi.org\/10.1038\/s41556-018-0271-4 (2019).","journal-title":"Nat. Cell Biol."},{"key":"9124_CR15","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1016\/j.celrep.2017.11.005","volume":"21","author":"T Takebe","year":"2017","unstructured":"Takebe, T. et al. Massive and reproducible production of liver buds entirely from human pluripotent stem cells. Cell Rep. 21, 2661\u20132670. https:\/\/doi.org\/10.1016\/j.celrep.2017.11.005 (2017).","journal-title":"Cell Rep."},{"key":"9124_CR16","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.jcyt.2013.06.003","volume":"15","author":"B Tumaini","year":"2013","unstructured":"Tumaini, B. et al. Simplified process for the production of anti-CD19-CAR-engineered T cells. Cytotherapy 15, 1406\u20131415. https:\/\/doi.org\/10.1016\/j.jcyt.2013.06.003 (2013).","journal-title":"Cytotherapy"},{"key":"9124_CR17","doi-asserted-by":"publisher","unstructured":"Phinney, D. G., Galipeau, J. & MSC COMMITTEE OF THE INTERNATIONAL SOCIETY OF CELL AND GENE THERAPY. Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at US academic centers. Cytotherapy 21, 782\u2013792 (2019). Doi:https:\/\/doi.org\/10.1016\/j.jcyt.2019.04.003","DOI":"10.1016\/j.jcyt.2019.04.003"},{"key":"9124_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF02581331","volume":"27","author":"C Ricordi","year":"1990","unstructured":"Ricordi, C. et al. Islet isolation assessment in man and large animals. Acta Diabetol. Lat. 27, 185\u2013195. https:\/\/doi.org\/10.1007\/BF02581331 (1990).","journal-title":"Acta Diabetol. Lat."},{"key":"9124_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim, J., Koo, B. K. & Knoblich, J. A. Human organoids: Model systems for human biology and medicine. Nat. Rev. Mol. Cell Biol. 21, 571\u2013584. https:\/\/doi.org\/10.1038\/s41580-020-0259-3 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9124_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41578-021-00279-y","volume":"6","author":"M Hofer","year":"2021","unstructured":"Hofer, M. & Lutolf, M. P. Engineering organoids. Nat. Rev. Mater. 6, 402\u2013420. https:\/\/doi.org\/10.1038\/s41578-021-00279-y (2021).","journal-title":"Nat. Rev. Mater."},{"key":"9124_CR21","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/sctm.19-0406","volume":"9","author":"BS Borys","year":"2020","unstructured":"Borys, B. S. et al. Optimized serial expansion of human induced pluripotent stem cells using low-density inoculation to generate clinically relevant quantities in vertical-wheel bioreactors. Stem Cells Transl. Med. 9, 1036\u20131052. https:\/\/doi.org\/10.1002\/sctm.19-0406 (2020).","journal-title":"Stem Cells Transl. Med."},{"key":"9124_CR22","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/bit.26719","volume":"115","author":"YY Lipsitz","year":"2018","unstructured":"Lipsitz, Y. Y., Tonge, P. D. & Zandstra, P. W. Chemically controlled aggregation of pluripotent stem cells. Biotechnol. Bioeng. 115, 2061\u20132066. https:\/\/doi.org\/10.1002\/bit.26719 (2018).","journal-title":"Biotechnol. Bioeng."},{"key":"9124_CR23","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/sctm.20-0453","volume":"10","author":"F Manstein","year":"2021","unstructured":"Manstein, F. et al. High density bioprocessing of human pluripotent stem cells by metabolic control and in silico modeling. Stem Cells Transl. Med. 10, 1063\u20131080. https:\/\/doi.org\/10.1002\/sctm.20-0453 (2021).","journal-title":"Stem Cells Transl. Med."},{"key":"9124_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10616-011-9368-3","volume":"63","author":"W Hu","year":"2011","unstructured":"Hu, W., Berdugo, C. & Chalmers, J. J. The potential of hydrodynamic damage to animal cells of industrial relevance: Current understanding. Cytotechnology 63, 445\u2013460. https:\/\/doi.org\/10.1007\/s10616-011-9368-3 (2011).","journal-title":"Cytotechnology"},{"key":"9124_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/cyto.a.23690","volume":"95","author":"A Reichard","year":"2019","unstructured":"Reichard, A. & Asosingh, K. Best practices for preparing a single cell suspension from solid tissues for flow cytometry. Cytometry A 95, 219\u2013226. https:\/\/doi.org\/10.1002\/cyto.a.23690 (2019).","journal-title":"Cytometry A"},{"key":"9124_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/jbm.b.34393","volume":"108","author":"R Cao","year":"2020","unstructured":"Cao, R., Avgoustiniatos, E., Papas, K., de Vos, P. & Lakey, J. R. T. Mathematical predictions of oxygen availability in micro- and macro-encapsulated human and porcine pancreatic islets. J. Biomed. Mater. Res. B Appl. Biomater. 108, 343\u2013352. https:\/\/doi.org\/10.1002\/jbm.b.34393 (2020).","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"9124_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrd.2016.232","volume":"16","author":"T Desai","year":"2017","unstructured":"Desai, T. & Shea, L. D. Advances in islet encapsulation technologies. Nat. Rev. Drug Discov. 16, 338\u2013350. https:\/\/doi.org\/10.1038\/nrd.2016.232 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9124_CR28","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1517\/14712598.2015.1055242","volume":"15","author":"AA Tomei","year":"2015","unstructured":"Tomei, A. A., Villa, C. & Ricordi, C. Development of an encapsulated stem cell-based therapy for diabetes. Exp. Opin. Biol. Ther. 15, 1321\u20131336. https:\/\/doi.org\/10.1517\/14712598.2015.1055242 (2015).","journal-title":"Exp. Opin. Biol. Ther."},{"key":"9124_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.freeradbiomed.2017.10.003","volume":"113","author":"TL Place","year":"2017","unstructured":"Place, T. L., Domann, F. E. & Case, A. J. Limitations of oxygen delivery to cells in culture: An underappreciated problem in basic and translational research. Free Radic. Biol. Med. 113, 311\u2013322. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.10.003 (2017).","journal-title":"Free Radic. Biol. Med."},{"key":"9124_CR30","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1038\/s41467-020-17165-w","volume":"11","author":"D Doi","year":"2020","unstructured":"Doi, D. et al. Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson\u2019s disease. Nat. Commun. 11, 3369. https:\/\/doi.org\/10.1038\/s41467-020-17165-w (2020).","journal-title":"Nat. Commun."},{"key":"9124_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.healun.2018.11.002","volume":"38","author":"R Tabei","year":"2019","unstructured":"Tabei, R. et al. Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell - Derived cardiomyocytes. J. Heart Lung Transplant. 38, 203\u2013214. https:\/\/doi.org\/10.1016\/j.healun.2018.11.002 (2019).","journal-title":"J. Heart Lung Transplant."},{"key":"9124_CR32","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1016\/j.biomaterials.2010.12.035","volume":"32","author":"SH Bhang","year":"2011","unstructured":"Bhang, S. H. et al. Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells. Biomaterials 32, 2734\u20132747. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.12.035 (2011).","journal-title":"Biomaterials"},{"key":"9124_CR33","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nn1402","volume":"8","author":"K Watanabe","year":"2005","unstructured":"Watanabe, K. et al. Directed differentiation of telencephalic precursors from embryonic stem cells. Nat. Neurosci. 8, 288\u2013296. https:\/\/doi.org\/10.1038\/nn1402 (2005).","journal-title":"Nat. Neurosci."},{"key":"9124_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/dgd.12714","volume":"63","author":"T Shimizu","year":"2021","unstructured":"Shimizu, T., Yamagata, K. & Osafune, K. Kidney organoids: Research in developmental biology and emerging applications. Dev. Growth Differ. 63, 166\u2013177. https:\/\/doi.org\/10.1111\/dgd.12714 (2021).","journal-title":"Dev. Growth Differ."},{"key":"9124_CR35","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1038\/srep03594","volume":"4","author":"M Nakagawa","year":"2014","unstructured":"Nakagawa, M. et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci. Rep. 4, 3594. https:\/\/doi.org\/10.1038\/srep03594 (2014).","journal-title":"Sci. Rep."},{"key":"9124_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.stemcr.2018.12.012","volume":"12","author":"L Velazco-Cruz","year":"2019","unstructured":"Velazco-Cruz, L. et al. Acquisition of dynamic function in human stem cell-derived \u03b2 cells. Stem Cell Rep. 12, 351\u2013365. https:\/\/doi.org\/10.1016\/j.stemcr.2018.12.012 (2019).","journal-title":"Stem Cell Rep."},{"key":"9124_CR37","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/db19-0728","volume":"69","author":"T Mochida","year":"2020","unstructured":"Mochida, T. et al. Insulin-deficient diabetic condition upregulates the insulin-secreting capacity of human induced pluripotent stem cell-derived pancreatic endocrine progenitor cells after implantation in mice. Diabetes 69, 634\u2013646. https:\/\/doi.org\/10.2337\/db19-0728 (2020).","journal-title":"Diabetes"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09124-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09124-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09124-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:32:17Z","timestamp":1669339937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09124-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9124"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09124-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,25]]},"assertion":[{"value":"24 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed as a collaborative study between Kyoto University, Takeda Pharmaceutical Company, and Toyo Seikan Group Holdings. T.T. is a scientific advisor of Orizuru Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5221"}}